Medical - Drugs
Industry Rank
More Info
The Zacks Industry Rank assigns a rating to each of the 253 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 253), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (253 out of 253) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
The Zacks Industry Rank assigns a rating to each of the 253 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 253), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (253 out of 253) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
-0.74%
1Y Return More Info
1 Year (YR) Return shows the percentage price charge for the respective Industry over the last 12 months to date.
Updated Jan 20
Sector: Medical
Performance
| Total Return % | IVV(iShares-SP500) | |
|---|---|---|
| 1 Month | -1.80 | 3.99 |
| 3 Months | 9.20 | 12.28 |
| YTD | 5.05 | NA |
| 1 Year | -0.74 | 17.30 |
| 3 Years | -21.11 | 42.99 |
| 5 Years | -1.72 | 121.35 |
Medical - Drugs Performance
Key Metrics for
Industry Earnings
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| PE (F1) | 14.86 | 20.84 |
| PEG (Ratio) | 1.17 | 2.59 |
| Proj EPS Growth | 20.00% | 11.86% |
| Hist EPS Growth | 9.37% | 9.72% |
| Net Margin | -142.81% | 10.44% |
| Hist Sales Growth | 8.23% | 5.81% |
| Hist Dividend Growth | 0.00% | 0.95% |
Financial Ratios
| Industry | IVV(iShares-SP500) | |
|---|---|---|
| Beta | 1.23 | 1.07 |
| ROE | -54.64 | 15.37 |
| ROA | -40.08 | 5.59 |
| ROI | -48.93 | 9.02 |
| Debt-to-Equity | 0.00 | 0.70 |
| Current Ratio | 3.78 | 1.38 |
| Cash Flow ($/share) | -11.33 | 1,961.34 |
| Price to Book | 4.48 | 0.95 |
| Price To Sales | 10.63 | 3.02 |
| Dividend Yield | 0.00% | 1.43% |